Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-992-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral: non toxic
Dermal: non toxic
Inhalation: no sufficient data available
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Oral
Based OECD 401 test results, BPS CAS 80-09-1, LD50 values are greater than 2000 and 5000 mg/Kg respectively. Several LD50 values from different tests are available, as a supporting: they indicate that the acute oral toxicity of BPS is low.1 2 3
2,4'-sulfonyldiphenol CAS 5397-34-2 is considered a low acute oral toxicant (C&L ECHA Inventory), but no data is available.
Also data on benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1), CAS 825-90-1 is not available.
The substance is the salified form of phenol sulfonic acid, which is a very acidic substance (comparable to sulphuric acid) and is almost completely ionised in watery environments, even at low pH.
Oral route values for rat and mouse of 1900 and 1500 mg/kg bw respectively, are available; this toxicity is probably due more to thegastro-intestinal corrosive property than the effective toxicity of the substance.4
The product DCB 58 % is neutralized, thus, more realistic data on salified similar substances called hydrotropes, can be considered.
A category approach evaluation has been done for the sodium xylenesulphonate evaluation. The estimated toxicological property of this substance can be helpful (in read across as well) to understand the toxicity of sodium sulphonated phenols, part of the intermediate DCB.
The sodium xylenesulphonate is considered non toxic by acute oral exposure.5
Estimated lethal oral doses of phenol in adults vary widely, from 1 g to 65 g. The substance is already classified as an oral toxicant (category 3, H301).6
Dermal
Reported several data on BPS CAS 80-09-1, suggest a low hazard concern for acute dermal exposure (LD50 > 5000 mg/Kg/day bw).1 2 3
In addition, the estimated Kp of BPS is 0.000767 cm/hr and this value suggests that it could be less skin absorbed (EPI Suite v. 4.11).
2,4'-sulfonyldiphenol CAS 5397-34-2 is considered a low acute dermal toxicant (C&L ECHA Inventory), but no data is available.
Also, data on benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1), CAS 825-90-1 are not available.
The substance is the salified form of phenol sulfonic acid, which is a very acidic substance (comparable to sulphuric acid) and is almost completely ionised in watery environments, even at low pH. Taking into consideration its corrosive nature, studies would cause unnecessary harm to laboratory animals. Moreover, because of the high polarity and high water solubility, the substance would be expected to be absorbed into the systemic circulation to a minimal extent.4
The product is neutralized, thus, more realistic data on salified similar substances called hydrotropes, can be considered.
A category approach evaluation has been done for the sodium xylenesulphonate.
The acute dermal LD50 for sodium xylene sulphonate is > 2000 mg/kg bw. A category approach evaluation has also been done and defined it as non toxic for the dermal exposure.5
In addition, in a modelling study of 2010, the 2.8% of dermal absorption (low value) was calculated for sodium xylenesulphonate.5
Phenol, CAS 108-95-2 is readily absorbed by dermal contact with phenol liquid or phenol vapour, so systemic effects can also result from dermal exposure. Several acute lethality assays have been reported; in fact the substance is already classified in the Annex VI of CLP as a dermal toxicant (category 3, H311).6
Inhalation
No data is available regarding the acute inhalation hazard of BPS CAS 80-09-1.
2,4'-sulfonyldiphenol CAS 5397-34-2 is considered a low acute inhalation toxicant (C&L ECHA Inventory), but no data are available.
Also, data on benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1), CAS 825-90-1 is not available.
The substance is the salified form of phenol sulfonic acid, which is a very acidic substance (comparable to sulphuric acid).
The product is neutralized, therefore, data on salified sulphonated phenols (similar substances called hydrotropes), can be considered.
A category approach evaluation is available for the sodium xylenesulphonate. A read across evaluation was done to define the toxicity of sodium xylenesulphonate by inhalation and defined it as non toxic by inhalation exposure.5
Several acute lethality assays on phenol CAS 108-95-2 have been reported, in fact, the substance is already classified under CLP, annex VI, as an inhalation toxicant (category 3, H331).6
References:
1ECHA Registration Dossier, BPS CAS 80-09-1;
2SIDS INITIAL ASSESSMENT PROFILE, CAS 80-09-1, CoCAM 4, 16-18 April 2013;
3EPA, U. S. Environmental Protection Agency, Bisphenol A alternatives in thermal paper, Final Report, January 2014;
4HPV Assessment Report On Hydroxybenzenesulphonic acid CAS No. 1333-39-7, 2004, NOTOX;
5ECHA Registration Dossier, Sodium xylenesulphonate, CAS 1300-72-7;
6Toxicological review of phenol. EPA, IRIS, 2002, EPA/635/R-02/006.
Justification for classification or non-classification
Oral
In order to classify the whole mixture DCB for the oral toxicity, the available classification and the results of the reported studies of every known component has been taken into account.
4,4'-sulfonyldiphenol (BPS): non classified
Benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1)- hydrotropes, sodium xilene sulphonate (category approach): non classified
2,4'-sulfonyldiphenol: H302 (C&L ECHA Inventory).
Phenol: H301
Approximately 48% of the organic part of the intermediate under registration is composed of BPS.
Approximately 14% of the organic part of the mixture is the salified form of the phenol sulfonic acid, the benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1). A category approach based on the hydrotropes can be taken into account for the classification of the whole intermediate mixture DCB. In fact, the properties of the salified form can be covered in read across with sodium xylenesulphonate (data available).
2,4'-sulfonyldiphenol is present at ca 6%.
Phenol is present in a low concentration (1.8%), therefore, it does not influence the classification of the intermediate DCB for this endpoint.
According to the CLP Regulation 1272/2008/EC, 3.1 section, based on the information available, the intermediate DCB 58% is not classified as an acute oral toxicant.
Dermal
In order to classify the whole mixture for acute dermal toxicity, the available classification and the results of the reported studies of every known component has been taken into account.
4,4'-sulfonyldiphenol (BPS): non classified
Benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1)- hydrotropes, sodium xilene sulphonate (category approach): non classified
2,4'-sulfonyldiphenol: H312
Phenol: H311
Approximately 48% of the organic part of the intermediate under registration is composed of BPS.
Approximately 14% of the organic part of the mixture is the salified form of the phenol sulfonic acid, the benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1).
A category approach based on the hydrotropes can be taken into account for the classification of the whole intermediate mixture DCB. In fact, the properties of the salified form can be covered in read across with sodium xylenesulphonate (data available).
Phenol, a dermal toxicant, is present in a low concentration (1.8%), therefore, it does not influence the classification of the intermediate DCB for dermal toxicity.
According to the CLP Regulation 1272/2008/EC, 3.1 section, based on the information available, the intermediate DCB 58% is not classified as an acute dermal toxicant.
Inhalation
In order to classify the whole mixture DCB for inhalation toxicity, the available classification and the results of the reported studies of every known component has been taken into account.
4,4'-sulfonyldiphenol (BPS): no data
Benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1)- hydrotropes, sodium xylenesulphonate (category approach): non classified
2,4'-sulfonyldiphenol: H332
phenol: H331
Approximately 48% of the organic part of the intermediate under registration is composed of BPS.
Approximately 14% of the organic part of the mixture is the salified form of the phenol sulfonic acid (p-APS), benzenesulfonic acid, 4-hydroxy-, sodium salt (1:1).
A category approach based on the hydrotropes can be taken into account for the classification of the whole intermediate mixture DCB. In fact the properties of the salified form can be covered in read across with sodium xylenesulphonated (data available; not classified).
Phenol, an inhalation toxicant, is present in a low concentration (1.8%). Therefore, it does not influence the classification of the intermediate DCB for inhalation toxicity.
Despite the limited data available, the classification is considered inconclusive, because data on the major component (ca. 48 %) is not available.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.